These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37496051)

  • 21. PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
    Ghilardi C; Moreira-Barbosa C; Brunelli L; Ostano P; Panini N; Lupi M; Anastasia A; Fiordaliso F; Salio M; Formenti L; Russo M; Arrigoni E; Chiaradonna F; Chiorino G; Draetta G; Marszalek JR; Vellano CP; Pastorelli R; Bani M; Decio A; Giavazzi R
    Cancer Res; 2022 Apr; 82(7):1423-1434. PubMed ID: 35131872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer.
    Guo J; Li X; Zhang W; Chen Y; Zhu S; Chen L; Xu R; Lv Y; Wu D; Guo M; Liu X; Lu W; Deng H
    Sci Rep; 2019 Sep; 9(1):12628. PubMed ID: 31477750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) does not activate transcription in mammalian mitochondria.
    Harmel J; Ruzzenente B; Terzioglu M; Spåhr H; Falkenberg M; Larsson NG
    J Biol Chem; 2013 May; 288(22):15510-9. PubMed ID: 23599432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
    Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
    J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation.
    Liu JY; Chen YJ; Feng HH; Chen ZL; Wang YL; Yang JE; Zhuang SM
    Cell Death Dis; 2021 Oct; 12(11):970. PubMed ID: 34671012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of miR-629 Inhibits Ovarian Cancer Malignant Behaviors by Targeting Testis-Specific Y-Like Protein 5.
    Shao L; Shen Z; Qian H; Zhou S; Chen Y
    DNA Cell Biol; 2017 Dec; 36(12):1108-1116. PubMed ID: 28972400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
    Li D; Wang M
    Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.
    Vescarelli E; Gerini G; Megiorni F; Anastasiadou E; Pontecorvi P; Solito L; De Vitis C; Camero S; Marchetti C; Mancini R; Benedetti Panici P; Dominici C; Romano F; Angeloni A; Marchese C; Ceccarelli S
    J Exp Clin Cancer Res; 2020 Jan; 39(1):3. PubMed ID: 31898520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
    Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
    Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
    [No Abstract]   [Full Text] [Related]  

  • 33. LRPPRC and SLIRP synergize to maintain sufficient and orderly mammalian mitochondrial translation.
    Rubalcava-Gracia D; Bubb K; Levander F; Burr SP; August AV; Chinnery PF; Koolmeister C; Larsson NG
    Nucleic Acids Res; 2024 Oct; 52(18):11266-11282. PubMed ID: 39087558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OXPHOS-targeting drugs in oncology: new perspectives.
    Kalyanaraman B; Cheng G; Hardy M; You M
    Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
    Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
    Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer.
    Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ
    J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
    Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
    Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
    Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
    EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway.
    Li Y; Wang J; Wang F; Chen W; Gao C; Wang J
    Cell Biol Toxicol; 2022 Oct; 38(5):809-824. PubMed ID: 33978933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.
    Pastò A; Bellio C; Pilotto G; Ciminale V; Silic-Benussi M; Guzzo G; Rasola A; Frasson C; Nardo G; Zulato E; Nicoletto MO; Manicone M; Indraccolo S; Amadori A
    Oncotarget; 2014 Jun; 5(12):4305-19. PubMed ID: 24946808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.